Indefinite Delivery Contract 36C25626D0035
- Not listed
- Cepheid Inc. has been awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs' Veterans Integrated Service Network 8 (VISN 8) with a ceiling value of $9,248,933.20 and an ultimate completion date of May 18, 2030. The contract, which commenced on May 19, 2025, encompasses molecular analyzer leasing and cost-per-test services to support clinical laboratory operations across VISN 8 medical facilities. As a leading manufacturer of advanced molecular diagnostic...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs Veterans Integrated Service Network 8 (VISN 8) on April 1, 2026, with a contract ceiling value of $3.5 million and ultimate completion date of September 30, 2029. This civilian agency procurement carries no set-aside designation and establishes an indefinite quantity framework for the supply of Cepheid GeneXpert reagents and supplies. The contract...
- Cepheid, Inc. has been awarded a single-award Indefinite Delivery Contract (IDC) by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) with a ceiling value of $3.4 million and an ultimate completion date of March 31, 2026. The contract, awarded April 1, 2024, procures Cepheid molecular diagnostic testing kits designed for use with Cepheid GeneXpert analyzers currently deployed at VA Southern Nevada Healthcare System facilities in Las Vegas, Nevada. The test kits...
- Cepheid has been awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 6 (VISN 6) valued at $186,420.00, with a performance period extending through September 30, 2030. The contract, awarded on October 1, 2025, encompasses GeneXpert system service agreement services for the Salisbury VA Medical Center Biomedical Engineering Service located in Salisbury, North Carolina. This procurement falls under NAICS code 811210...
- The Department of Veterans Affairs Veterans Integrated Service Network 4 awarded a single-award Indefinite Delivery Contract to Cepheid Inc., a for-profit molecular diagnostic solutions manufacturer headquartered in Sunnyvale, California, with a ceiling value of $4,115,434.10 and an ultimate completion date of September 20, 2029. The contract, awarded on September 21, 2024, utilizes firm fixed-price delivery order pricing with no small business set-aside designation. The primary scope...
- On December 22, 2025, the Department of Veterans Affairs' Veterans Integrated Service Network 17 (VISN 17) awarded a single-award Indefinite Delivery Contract to Cepheid Inc. valued at $6.74 million with a ceiling completion date of December 28, 2029. This civilian healthcare procurement, which contains no set-aside designation, establishes a firm fixed-price vehicle for the supply of diagnostic reagents and test kits specifically designed for Cepheid's GeneXpert diagnostic platform. The initial...
- Cepheid Inc., a molecular diagnostic solutions manufacturer headquartered in Sunnyvale, California, was awarded a single-award Indefinite Delivery Contract by Veterans Integrated Service Network 20 (VISN 20) of the Department of Veterans Affairs on September 9, 2024. The contract, valued at $4.3 million with an ultimate completion date of September 8, 2029, establishes an indefinite delivery vehicle for the procurement of reagents and consumables for laboratory tests. The contract carries no...
- Cepheid Inc. has been awarded a single-award Blanket Purchase Agreement by the Department of Veterans Affairs Veterans Integrated Service Network 19 (VISN 19) with a ceiling value of $6.59 million and a performance period extending from October 1, 2025, through September 30, 2027. The procurement, issued as Request for Quote #36C25925Q0594, is for molecular diagnostic testing reagents and consumables compatible with Cepheid brand analyzers, encompassing 22 line items of swabs, collection kits,...
- The Department of Veterans Affairs (VA), Veterans Health Administration (VHA), Veterans Integrated Service Network 2 (VISN 2) awarded Cepheid, a for-profit manufacturer of molecular diagnostic solutions, a $518,924.36 firm fixed price Blanket Purchase Agreement (BPA) call contract to provide Cepheid's diagnostic testing products. The one-year contract, starting on September 11, 2023 and ending on September 10, 2024, will enable VISN 2 to continuously procure Cepheid's molecular diagnostic...
- The Department of Veterans Affairs (VA) Veterans Integrated Service Network 23 (VISN 23) awarded a single-award indefinite delivery contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at up to $749,999.99, enables the VA to continuously procure Cepheid's diagnostic equipment, reagents, consumables, and related maintenance and support services to support clinical testing programs serving veterans. Under this IDV, the VA has issued several firm...
Cepheid has been awarded a single-award Indefinite Delivery Contract by Veterans Integrated Service Network 17 (VISN 17), a civilian agency within the Department of Veterans Affairs, valued at $4.5 million with a period of performance extending through February 28, 2031. The contract, awarded on March 1, 2026, utilizes no set-aside provisions and establishes a firm fixed-price procurement framework for the GeneXpert Infinity 80-80 instrument lease with associated reagents and supplies. This IDV vehicle provides VISN 17 medical facilities with access to advanced molecular diagnostic equipment and consumable testing materials necessary to support clinical laboratory operations and infectious disease screening across the VA's integrated service network. The GeneXpert Infinity platform represents a critical component of VISN 17's point-of-care and centralized laboratory diagnostic capabilities, enabling rapid molecular testing for infectious diseases including COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other clinically significant pathogens. Under this indefinite delivery framework, VISN 17 maintains the flexibility to issue delivery orders for equipment leasing, reagent cartridges, test assays, and associated supplies based on clinical demand across its constituent medical centers. As the sole awardee, Cepheid's established expertise in molecular diagnostics and existing federal supply relationships with the Veterans Health Administration position the company to meet the diagnostic testing requirements of VISN 17's distributed network of healthcare facilities throughout the contract period.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 2/25/26 |